US: FDA reviews Merck's anticancer drug Keytruda
In: Chemical Business Newsbase, 2018-09-04
Zeitungsartikel
Zugriff:
Merck and Co has announced that The FDA has accepted and granted priority review for Keytruda for treating recurrent locally advanced or metastatic Merkel cell carcinoma. A decision is set to be made by 28 Dec 2018. Original Source: Nachrichten fuer Aussenhandel, http://www.maerkte-weltweit.de, Copyright MBM Martin Brueckner Medien GmbH 2018.
Titel: |
US: FDA reviews Merck's anticancer drug Keytruda
|
---|---|
Zeitschrift: | Chemical Business Newsbase, 2018-09-04 |
Veröffentlichung: | 2018 |
Medientyp: | Zeitungsartikel |
Schlagwort: |
|
Sonstiges: |
|